# AIPredictingASCVD-ColorectalCancer
Develop and validate AI models to predict ASCVD among those with right-side colorectal cancer, using routine EHR data

# Primary outcomes of interest:

ASCVD

Time to ASCVD, years

which is a composite outcome including individual cardiovascular outcomes of the following:

Peripheral vascular disease

Time to Peripheral vascular disease, years

Ischemic heart disease

Time to Ischemic heart disease, years

Myocardial infarction

Time to Myocardial infarction, years

Heart failure

Time to Heart failure, years

Atrial fibrillation

Time to Atrial fibrillation, years

VT/VF/SCD

Time to VT/VF/SCD, years

Syncope

Time to Syncope, years

Stroke/transient ischemic attack

Time to Stroke/transient ischemic attack, years

Intracranial hemorrhagic stroke

Time to Intracranial hemorrhagic stroke, years

# Secondary outcomes:

All-cause mortality

Time to mortality, years

Cardiovascular mortality

Time to CVD mortality, years

# Variables as AI model input:

# 1. Demographics

Male gender

Baseline age, years

# 2. Commorbidity diagnosis

Charlson standard commorbidity index

Hypertension

Hyperlipidaemia

Hypotension

Hypoglycemia

Diabetes mellitus

Chronic obstructive pulmonary disease

Asthma

Anemia

Upper gastrointestinal bleeding

Peptic ulcer disease

Autoimmune diseases

Renal diseases

Portal hypertension

Chronic liver disease and cirrhosis

Hepatitis B virus

Hepatitis C virus

Hemiplegia or paraplegia

Gout

Pneumonia and influenza

All-cause dementia

Anxiety disorder and depression

Sleep disorders

Schizophrenia

Hip fractures

Accidental falls

Biliary tract infection

Gastrointestinal infection

Intra-abdominal infection

Lower respiratory tract infection

Miscellaneous infection

Alcoholism

Tobacco use and dependence

Obesity

Family history of malignant neoplasm

# 3. Medications

ACEI/ARB

Calcium channel blockers

Alpha blockers

Beta-blockers

Diuretics for hypertension

Diuretics for heart failure

Lipid-lowering drugs

Statins and fibrates

Anticoagulants

Antiplatelets

Anti-diabetic drugs

Hormonal drugs

Steroids

Non-steroidal anti-inflammatory drugs

# 4. Laboratory examination tests:

# 4.1. Complete blood counts:

Mean corpuscular volume, fL

Basophil, x10^9/L

Eosinophil, x10^9/L

Lymphocyte, x10^9/L

Monocyte, x10^9/L

Neutrophil, x10^9/L

White blood bount, x10^9/L

Mean cell haemoglobin, pg

Platelet, x10^9/L

Reticulocyte, x10^9/L

Red blood count, x10^12/L

Hematocrit, L/L

# 4.2. Liver and renal functions:

K/Potassium, mmol/L

Urate, mmol/L

Albumin, g/L

Na/Sodium, mmol/L

Urea, mmol/L

Protein, g/L

Creatinine, umol/L

Alkaline phosphatase, U/L

Aspartate transaminase, U/L

Alanine transaminase, U/L

Bilirubin, umol/L

# 4.3. Lipid and glucose profiles:

Triglyceride, mmol/L

Low-density lipoprotein, mmol/L

High-density lipoprotein, mmol/L

Total cholesterol, mmol/L

Haemoglobin, g/dL

HbA1C, %

Fasting glucose, mmol/L

Systolic BP, mmHg

DiastolicBP, mmHg

